
Over the last decade, “telehealth” became a buzzword in conversations about health care innovation.
During the first months of the COVID-19 pandemic, it became the only avenue to care for many patients with cancer and other diseases.
In 2020, Medicare visits by way of telehealth increased 63-fold, from approximately 840,000 in 2019 to 52.7 million, according to a report from the U.S. Department of Health and Human Services.
“It became mainstream … all of the things blocking it got smushed away,” Stephen K. Klasko, MD, MBA, executive in residence, general catalyst and